Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NYSE:MRK
Tag: NYSE:MRK
AstraZeneca plc (ADR)(NYSE:AZN) Durvalumab Nabs Its First FDA Approval
-
May 2, 2017
0
MerckInc. (NYSE:MRK) Files An 8-K Results of Operations and Financial Condition
ME Staff 8-k
-
May 2, 2017
0
Merck & Co., Inc. (NYSE:MRK) Cholesterol Drug Vytorin Now Faces Competition
-
April 27, 2017
0
Merck & Co., Inc. (NYSE:MRK) Says Researchers Have 25 Scientific Data...
-
April 20, 2017
0
Merck & Co., Inc. (NYSE:MRK) To Present New Data From HCV...
Andy Parker
-
April 6, 2017
0
Merck & Co., Inc. (NYSE:MRK)’s Zepatier Will Be Covered In Quebec’s...
Andy Parker
-
March 22, 2017
0
Merck & Co., Inc. (NYSE:MRK) Sued By Numerous Plaintiffs Over Harm...
Andy Parker
-
March 16, 2017
0
FDA Endorses 3 New Drug Applications (NDAs) From Merck & Co.,...
-
March 7, 2017
0
Merck & Co., Inc. (NYSE:MRK) In $2.9 Billion Writedown After Market...
Andy Parker
-
February 24, 2017
0
Merck & Co., Inc. (NYSE:MRK) Files An 8-K Material Impairments
ME Staff 8-k
-
February 23, 2017
0
1
...
5
6
7
...
10
Page 6 of 10
